Table 2.
Diagnostic test results and symptoms in subjects with PTB (n=194) according to location of birth and documentation status
| US-born* | Foreign-born | |||
|---|---|---|---|---|
| N=61 | Documented N=62 |
Undocumented N=71 |
P value | |
| Diagnostic test results | ||||
| Multilobar or miliary infiltrates, n (%) | 41 (67) | 44 (71) | 44 (62) | 0.541a |
| Presence of cavitary lesions, n (%) | 20 (33) | 23 (37) | 26 (37) | 0.886a |
| Smear+c, n (%) | 38 (62) | 35 (56) | 47 (66) | 0.512a |
| Presence of symptoms suggestive of active PTBd | ||||
| Cough, n (%) | 40 (66) | 46 (74) | 59 (83) | 0.069a |
| Fever, n (%) | 32 (52) | 32 (52) | 46 (65) | 0.224a |
| Night sweats, n (%) | 19 (31) | 16 (26) | 31 (44) | 0.081a |
| Weight losse, n (%) | 28 (46) | 29 (47) | 35 (49) | 0.920a |
| Hemoptysis, n (%) | 9 (15) | 11 (18) | 24 (34) | 0.018a |
| Symptom duration suggestive of active PTB | ||||
| Symptom durationf, median weeks (range) | 4 (0–36) | 4 (0–104) | 8 (1–104) | 0.014b |
a
Chi-square test for 3 group comparison
b
Kruskall-Wallis test
c
At least one of initial three sputum smears positive for AFB regardless of quantity
d
Symptoms self-reported by patients
e
self-reported weight loss of more than 2 lbs
f
Longest duration of any one or several symptoms suggestive of PTB